Global Genomics Market Regional Analysis
Europe is expected to gain significant share in the global genomics market over the forecast period, owing to increasing launches of new products by key players. For instance, in April 2017, Illumina, Inc. announced launch of its new product VeriSeq NIPT Solution, it is a CE-IVD marked next-generation sequencing (NGS)-based approach to non-invasive prenatal testing (NIPT).This approach includes the CE-IVD marked library preparation and analysis software. This software enables fast, highly accurate, cost-effective, and non-invasive parenteral testing (NIPT).
Furthermore, Asia Pacific is also projected to witness significant growth in the global genomics market during the forecast period, owing to increasing collaboration activities by key players. For instance, in January 2018, 10X Genomics, Inc. collaborated with the Berry Genomics Co. Ltd. Under this collaboration, 10x Genomics, Inc. focuses on development of approaches for next generation non-invasive prenatal testing (NIPT) and developing and offering new services for Berry Genomics Co. Ltd.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients